AAAAAA
Results:
1-7
|
Results: 7
Authors:
Godley, PA
Taylor, M
Citation: Pa. Godley et M. Taylor, Renal cell carcinoma, CURR OPIN O, 13(3), 2001, pp. 199-203
Authors:
Kornblith, AB
Herndon, JE
Zuckerman, E
Godley, PA
Savarese, D
Vogelzang, NJ
Holland, JC
Citation: Ab. Kornblith et al., The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: A feasibility study, ANN ONCOL, 12(5), 2001, pp. 633-641
Authors:
Godley, PA
Rathore, SS
Kshirsagar, AV
Amamoo, MA
Schell, MJ
Freeman, J
Harris, RP
Citation: Pa. Godley et al., Retrospective classification of prostate-specific antigen tests: Differentiating screening from diagnostic clinical encounters, J CLIN EPID, 54(9), 2001, pp. 884-888
Authors:
Savarese, DM
Halabi, S
Hars, V
Akerley, WL
Taplin, ME
Godley, PA
Hussain, A
Small, EJ
Vogelzang, NJ
Citation: Dm. Savarese et al., Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: A final report of CALGB 9780, J CL ONCOL, 19(9), 2001, pp. 2509-2516
Authors:
Godley, PA
Ataga, KI
Citation: Pa. Godley et Ki. Ataga, Renal cell carcinoma, CURR OPIN O, 12(3), 2000, pp. 260-264
Authors:
Godley, PA
Schell, MJ
Citation: Pa. Godley et Mj. Schell, Adjusted odds ratios under nondifferential misclassification: Application to prostate cancer, J CLIN EPID, 52(2), 1999, pp. 129-136
Authors:
Godley, PA
Citation: Pa. Godley, Prostate cancer screening: Promise and peril - A review, CANCER DET, 23(4), 1999, pp. 316-324
Risultati:
1-7
|